Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure

BACKGROUND: There is a paucity of data about the mechanisms by which sacubitril/valsartan (also known as LCZ696) improves outcomes in patients with heart failure. Specifically, the effects of sacubitril/valsartan on vascular function and NO bioavailability have not been investigated. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Rishi K., Polhemus, David J., Li, Zhen, Yoo, Daniel, Koiwaya, Hiroshi, Scarborough, Amy, Goodchild, Traci T., Lefer, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866338/
https://www.ncbi.nlm.nih.gov/pubmed/29502102
http://dx.doi.org/10.1161/JAHA.117.008268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866338/
https://www.ncbi.nlm.nih.gov/pubmed/29502102
http://dx.doi.org/10.1161/JAHA.117.008268

Ejemplares similares